Selective AUTAC‐mediated ATP7B degradation unlocks cuproptosis vulnerability in pancreatic ductal adenocarcinoma
Open Access
- 27 October 2026
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (11)
Abstract
Cuproptosis arises from mitochondrial copper overload, yet how tumour cells evade this metabolic vulnerability remains unclear. We identify ATP7B as the central barrier to cuproptosis in pancreatic ductal adenocarcinoma (PDAC). ATP7B is aberrantly upregulated in PDAC and predicts poor prognosis. Its depletion increases intracellular copper, activates FDX1, DLAT/DLST lipoylation, disrupts tricarboxylic acid (TCA) metabolism, and reinstates cuproptosis in vitro and in vivo. Mechanistically, ATP7B undergoes ZBTB10‐driven K63‐linked ubiquitination, recognized by NBR1 for selective autophagic degradation. Leveraging this, we developed an ATP7B‐targeting autophagy‐targeting chimera (ATAUTAC) that promotes ATP7B clearance, amplifies copper‐driven mitochondrial metabolic perturbations, triggers cuproptosis, and inhibits tumour growth with favourable tolerability. Notably, ATAUTAC sensitizes PDAC to gemcitabine, overcoming resistance by exposing latent metabolic fragility. These findings establish ATP7B as a mechanistic hub of cuproptosis tolerance and demonstrate that autophagy‐based ATP7B degradation is a druggable strategy for copper‐dependent tumour eradication. ATAUTAC offers a promising avenue for precision therapy in PDAC and other refractory malignancies.Keywords
This publication has 39 references indexed in Scilit:
- Inducing potent ferroptosis in cancer cells by manipulation of ferritinophagy with a ferritin-targeted ATTECJournal of Controlled Release, 2025
- Zbtb16 determines the fate plasticity of cardiovascular progenitors through IGF2BP3-mediated mRNA stabilizationCell Reports, 2025
- Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA‐Methyltransferase 1 (DNMT1)/microRNA‐302a‐3p (miR‐302a‐3p)/ATPase Copper Transporting Beta (ATP7B) AxisMedcomm, 2025
- Phillygenin ameliorates myocardial ischemia-reperfusion injury by inhibiting cuproptosis via the autophagy-lysosome degradation of CTR1Free Radical Biology and Medicine, 2025
- Polymerization of ZBTB transcription factors regulates chromatin occupancyMolecular Cell, 2024
- Cuproptosis: Advances in Stimulus‐Responsive Nanomaterials for Cancer TherapyAdvanced Healthcare Materials, 2024
- Targeting the undruggables—the power of protein degradersScience Bulletin, 2024
- Advancing targeted protein degradation for metabolic diseases therapyPharmacological Research, 2022
- Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathwaySignal Transduction and Targeted Therapy, 2022
- Interference between copper transport systems and platinum drugsSeminars in Cancer Biology, 2021